First Look Analysts Research Calls for Thursday, April 13

By Paul Ausick Published Apr 13, 8:09AM EDT

Follow 24/7 Wall St. on Google

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

First Look Analysts Research Calls for Thursday, April 13 — © Mario Tama / Getty Images News via Getty Images

This report was sent to Briefing.com subscribers earlier today.

Upgrades:

> Chevron (CVX) upgraded to Sector Outperform from Sector Perform at Scotiabank; tgt raised to $200

> DraftKings (DKNG) upgraded to Neutral from Underperform at Exane BNP Paribas; tgt $17

> EOG Resources (EOG) upgraded to Sector Outperform from Sector Perform at Scotiabank; tgt lowered to $145

> Merck (MRK) upgraded to Buy from Neutral at Citigroup; tgt raised to $130

> Steven Madden (SHOO) upgraded to Buy from Neutral at Citigroup; tgt raised to $42

> SunPower (SPWR) upgraded to Neutral from Underperform at BofA Securities; tgt raised to $15

> World Wrestling (WWE) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $120

> V.F. Corp (VFC) upgraded to Buy from Hold at Edward Jones

Downgrades:

> BRF SA (BRFS) downgraded to Underperform from Neutral at BofA Securities

> CubeSmart (CUBE) downgraded to Peer Perform from Outperform at Wolfe Research

> Exxon Mobil (XOM) downgraded to Sector Perform from Sector Outperform at Scotiabank; tgt lowered to $135

> First Solar (FSLR) downgraded to Hold from Buy at Deutsche Bank; tgt raised to $230

> LSB Industries (LXU) downgraded to Hold from Buy at Jefferies; tgt lowered to $10

> LyondellBasell (LYB) downgraded to Hold from Buy at Jefferies; tgt lowered to $90

> National Storage Affiliates (NSA) downgraded to Underperform from Peer Perform at Wolfe Research

> Playtika (PLTK) downgraded to Underperform from Neutral at BofA Securities; tgt $10

> POSCO (PKX) downgraded to Underweight from Neutral at JP Morganowngrades:

Others:

> Broadcom (AVGO) initiated with a Buy at The Benchmark Company; tgt $770

> CCC Intelligent Solutions (CCCS) initiated with an Overweight at JP Morgan; tgt $11

> Costco (COST) initiated with an Outperform at William Blair

> CRISPR Therapeutics (CRSP) initiated with an Overweight at Cantor Fitzgerald; tgt $72

> FTC Solar (FTCI) initiated with a Buy at H.C. Wainwright; tgt $5

> General Motors (GM) initiated with a Neutral at Mizuho; tgt $39

> Intellia Therapeutics (NTLA) initiated with a Buy at Canaccord Genuity; tgt $66

> Magnite (MGNI) initiated with a Buy at B. Riley Securities; tgt $15

> Pliant Therapeutics (PLRX) initiated with an Outperform at Robert W. Baird; tgt $44

> Primerica (PRI) initiated with a Strong Buy at Raymond James; tgt $244

> PubMatic (PUBM) initiated with a Buy at B. Riley Securities; tgt $20

> Relay Therapeutics (RLAY) initiated with an Outperform at Raymond James; tgt $29

> RxSight (RXST) initiated with an Outperform at Oppenheimer; tgt $23

> Strategic Education (STRA) resumed with a Neutral at BofA Securities; tgt $103

> Verve Therapeutics (VERV) initiated with a Buy at Canaccord Genuity; tgt $29

> Vital Farms (VITL) initiated with a Hold at Needham

About the Author Paul Ausick →

Paul Ausick has been writing for a673b.bigscoots-temp.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.